Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032460

Enrollment

Unknown

Registered

2020-04-29

Start date

2020-01-20

Completion date

Unknown

Last updated

2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Swabs of pharynx were positive in nucleic acid test, grouping according to ICU admission

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria were confirmed patients with positive viral nucleic acid test of pharyngeal swab.

Exclusion criteria

Exclusion criteria: The exclusion criteria were patients who refused to be enrolled.

Design outcomes

Primary

Measure	Time frame
CRP, Cys, SAA, IL-6, ESR, PCT;myoglobin, troponin, lactate dehydrogenase, urea nitrogen, total bilirubin, aspartate aminotransaminase, alanine aminotransaminase;APTT, PT, fibrinogen, D-D, albumin, glucose, uric acid;white blood cell count, neutrophil count, lymphocyte count, monocyte count, platelet count, mean platelet volume;	—

Countries

China

Contacts

Public ContactWenting Li

The First Affiliated Hospital of university of Science and Technology of China

wtl9911002@163.com+86 13866683842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026